Effect of culture media on expansion properties of human umbilical cord matrix-derived mesenchymal cells

Cytotherapy

Volumn 14, Issue 8, 2012, Pages 948-953

  Salehinejad, Parvin ^a,b   Alitheen, Noorjahan Banu ^a   Nematollahi Mahani, Seyed Noureddin ^b,c   Ali, Abdul Manaf ^a   Omar, Abdul Rahman ^a   Janzamin, Ehsan ^d   Hajghani, Masoomeh ^e  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^e KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DMEM F12; Expansion; Human umbilical cord mesenchymal cells; Wharton's jelly; MEM Glutamax

Indexed keywords

CD34 ANTIGEN; CELL SURFACE MARKER; ENDOGLIN; HERMES ANTIGEN; THY 1 ANTIGEN;

ADIPOGENESIS; ALPHA MINIMUM ESSENTIAL MEDIUM GLUTAMAX; ARTICLE; BONE DEVELOPMENT; CALCULATION; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DULBECCOS MODIFIED EAGLES MEDIUM F12; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYME CELL; PRIORITY JOURNAL; UMBILICAL CORD;

EID: 84865731754     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2012.684377     Document Type: Article

References (30)

1. Carlin R, Davis D, Weiss M, Schultz B, Troyer D. Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol. 2006;4:8.
2. Ishige I, Nagamura-Inoue T, Honda MJ, Harnprasopwat R, Kido M, Sugimoto M, et al. Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord. Int J Hematol. 2009;90:261-9.
3. Kawauchi S, Terasaki H, Katano M, Murase J, Masuda Y, Tamura T, et al. Quality control and monitoring for the isolation process of mesenchymal stem cells and their differentiation into osteoblasts. Genet Test Mol Biomarkers. 2010;14:269-82.
4. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2006;24:462-71.
5. Seebach C, Henrich D, Tewksbury R, Wilhelm K, Marzi I. Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions. Calcif Tissue Int. 2007;80:294-300.
6. Matsuzuka T, Rachakatla RS, Doi C, Maurya DK, Ohta N, Kawabata A, et al. Human umbilical cord matrix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice. Lung Cancer. 2010;70:28-36.
7. Salehinejad P, Alitheen NB, Ali AM, Omar AR, Mohit M, Janzamin E, et al. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly. In Vitro Cell Dev Biol Anim. 2012;48:75-83.
8. Petsa A, Gargani S, Felesakis A, Grigoriadis N, Grigoriadis I. Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications. In Vitro Cell Dev Biol Anim. 2009;45:573-6.
9. Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay G, Demiralp D, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells. 2007;25:319-331.
10. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol. 2006;44:215-30.
11. Pytlik R, Stehlik D, Soukup T, Kalbacova M, Rypacek F, Trc T, et al. The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering. Biomaterials. 2009;30:3415-27.
12. Sato K, Kondo M, Sakuta K, Hosoi A, Noji S, Sugiura M, et al. Impact of culture medium on the expansion of T cells for immunotherapy. Cytotherapy. 2009;11:936-46.
13. Esposito MT, Di Noto R, Mirabelli P, Gorrese M, Parisi S, Montanaro D, et al. Culture conditions allow selection of different mesenchymal progenitors from adult mouse bone marrow. Tissue Eng Part A. 2009;15:2525-36.
14. Nematollahi-Mahani SN, Rezazadeh-Kermani M, Mehrabani M, Nakhaee N. Cytotoxic effects of Tecurium polium on some established cell lines. Pharmaceut Biol. 2007;45:295-8.
15. Aslan H, Sheyn D, Gazit D. Genetically engineered mesenchymal stem cells: applications in spine therapy. Regen Med. 2009;4:99-108.
16. Coelho MJ, Fernandes MH. Human bone cell cultures in biocompatibility testing. II. Effect of ascorbic acid, betaglycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials. 2000;21:1095-102.
17. Patel M, Smith AJ, Sloan AJ, Smith G, Cooper PR. Phenotype and behaviour of dental pulp cells during expansion culture. Arch Oral Biol. 2009;54:898-908.
18. Turnovcova K, Ruzickova K, Vanecek V, Sykova E, Jendelova P. Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media. Cytotherapy. 2009;11:874-85.
19. Lund P, Pilgaard L, Duroux M, Fink T, Zachar V. Effect of growth media and serum replacements on the proliferation and differentiation of adipose-derived stem cells. Cytotherapy. 2009;11:189-97.
20. Nekanti U, Rao VB, Bahirvani AG, Jan M, Totey S, Ta M. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev. 2010;19:117-30.
21. Schop D, Janssen FW, van Rijn LD, Fernandes H, Bloem RM, de Bruijn JD, et al. Growth, metabolism, and growth inhibitors of mesenchymal stem cells. Tissue Eng Part A. 2009;15:1877-86.
22. Christie A, Butler M. Growth and metabolism of a murine hybridoma in cultures containing glutamine-based dipeptides. Focus. 1994;16:9-13.
23. Schugar RC, Chirieleison SM, Wescoe KE, Schmidt BT, Askew Y, Nance JJ, et al. High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Biotechnol. 2009;2009:789526.
24. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells. 2006;24:781-92.
25. Hinoi E, Fujimori S, Takemori A, Yoneda Y. Cell death by pyruvate deficiency in proliferative cultured calvarial osteoblasts. Biochem Biophys Res Commun. 2002;294:1177-83.
26. Baer PC, Griesche N, Luttmann W, Schubert R, Luttmann A, Geiger H. Human adipose-derived mesenchymal stem cells in vitro: evaluation of an optimal expansion medium preserving stemness. Cytotherapy. 2009;12:96-106.
27. Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plasticadherent cells from human bone marrow. Proc Natl Acad Sci USA. 2000;97:3213-8.
28. Nematollahi-Mahani S, Rezazadekermani M, Latifpour M, Salehinejad P. Biological and biochemical characteristics of human umbilical cord mesenchymal cells. J Reprod Infert. 2009;10:7-15.
29. Leeb C, Jurga M, McGuckin C, Moriggl R, Kenner L. Promising new sources for pluripotent stem cells. Stem Cell Rev. 2009;6:15-26.
30. Russ HA, Ravassard P, Kerr-Conte J, Pattou F, Efrat S. Epithelial - mesenchymal transition in cells expanded in vitro from lineage-traced adult human pancreatic beta cells. PLoS One. 2009;4:e6417.